Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DWCH
2776
DELISTED
Datawatch Corp
DWCH
| $564K | ﹤0.01% |
76,100
+27,500
| +57% | +$174K |
2015 Q4
3 quarters
|
|
2777
Highway Holdings
HIHO
$3.98M
| $558K | ﹤0.01% |
128,900
+8,800
| +7% | +$39K |
2013 Q2
13 quarters
|
|
2778
Limoneira
LMNR
$218M
| $558K | ﹤0.01% |
29,500
+9,100
| +45% | +$164K |
2014 Q4
7 quarters
|
|
2779
Veru
VERU
$41.9M
| $558K | ﹤0.01% |
45,720
-8,800
| -16% | -$115K |
2013 Q2
13 quarters
|
|
|
IMH
2780
DELISTED
Impac Mortgage Holdings Inc.
IMH
| $554K | ﹤0.01% |
+42,000
| New | +$682K |
2016 Q3
0 quarters
|
|
2781
Flexible Solutions
FSI
$77.3M
| $553K | ﹤0.01% |
249,200
+181,100
| +266% | +$329K |
2015 Q2
5 quarters
|
|
|
WPRT
2782
Westport Fuel Systems
WPRT
$34.6M
| $551K | ﹤0.01% |
34,238
+30,968
| +947% | +$452K |
2014 Q4
7 quarters
|
|
|
TSRI
2783
DELISTED
TSR Inc. New
TSRI
| $549K | ﹤0.01% |
73,450
+32,900
| +81% | +$188K |
2013 Q2
13 quarters
|
|
2784
Scansource
SCSC
$1.23B
| $544K | ﹤0.01% |
14,910
-21,100
| -59% | -$822K |
2016 Q2
1 quarter
|
|
|
VTAE
2785
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $544K | ﹤0.01% |
+26,000
| New | +$299K |
2016 Q3
0 quarters
|
|
|
CCRN
2786
DELISTED
Cross Country Healthcare
CCRN
| $541K | ﹤0.01% |
45,917
-92,401
| -67% | -$1.22M |
2013 Q2
13 quarters
|
|
|
MDLY
2787
DELISTED
Medley Management Inc
MDLY
| $541K | ﹤0.01% |
+6,430
| New | +$478K |
2016 Q3
0 quarters
|
|
|
VSR
2788
DELISTED
Versar, Inc.
VSR
| $541K | ﹤0.01% |
346,500
+8,385
| +2% | +$12K |
2013 Q2
13 quarters
|
|
2789
Integer Holdings
ITGR
$4.3B
| $540K | ﹤0.01% |
+24,900
| New | +$637K |
2016 Q3
0 quarters
|
|
2790
CVD Equipment Corp
CVV
$29.1M
| $539K | ﹤0.01% |
64,500
+7,100
| +12% | +$61.4K |
2015 Q2
5 quarters
|
|
|
AMOV
2791
DELISTED
America Movil SAB de CV
AMOV
| $539K | ﹤0.01% |
50,068
+3,392
| +7% | +$38.1K |
2015 Q1
6 quarters
|
|
2792
Sypris Solutions
SYPR
$47.4M
| $538K | ﹤0.01% |
522,700
-1,300
| -0.2% | -$1.26K |
2013 Q2
13 quarters
|
|
|
POT
2793
DELISTED
Potash Corp Of Saskatchewan
POT
| $537K | ﹤0.01% |
33,000
-141,299
| -81% | -$2.33M |
2015 Q2
5 quarters
|
|
|
ETRM
2794
DELISTED
EnteroMedics Inc.
ETRM
| $531K | ﹤0.01% |
56,163
+52,584
| +1,469% | +$714K |
2016 Q2
1 quarter
|
|
2795
Genasys
GNSS
$62.4M
| $528K | ﹤0.01% |
282,100
-11,500
| -4% | -$21.9K |
2014 Q3
8 quarters
|
|
|
RHE
2796
DELISTED
Regional Health Properties, Inc.
RHE
| $528K | ﹤0.01% |
21,142
-775
| -4% | -$20.2K |
2014 Q1
10 quarters
|
|
|
PSV
2797
DELISTED
Hermitage Offshore Services Ltd.
PSV
| $527K | ﹤0.01% |
14,060
-5,400
| -28% | -$225K |
2015 Q4
3 quarters
|
|
2798
SiNtx Technologies
SINT
$14.1M
| – | – |
0
| – | – |
2014 Q4
7 quarters
|
|
2799
Teekay Tankers
TNK
$3.68B
| $522K | ﹤0.01% |
+25,775
| New | +$578K |
2016 Q3
0 quarters
|
|
|
NTUS
2800
DELISTED
Natus Medical Inc
NTUS
| $519K | ﹤0.01% |
+13,200
| New | +$526K |
2016 Q3
0 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.